Atrial natriuretic factor inhibits adenylate cyclase activity

Biochemical and Biophysical Research Communications
M B Anand-SrivastavaJ Genest

Abstract

The synthetic atrial natriuretic factor (ANF) (8- 33AA ) inhibited adenylate cyclase activity in aorta washed particles, mesenteric artery, and renal artery homogenates in a concentration dependent manner with an apparent Ki between 0.1 to 1nM . The extent of inhibition of adenylate cyclase by ANF varied from tissue to tissue. The adenylate cyclase from mesenteric artery and renal artery was inhibited to a greater extent as compared to that from aorta. ANF was also able to inhibit the stimulatory effects of hormones on adenylate cyclase activity and of agents such as F- and forskolin which activate adenylate cyclase by receptor- independent mechanism. In addition, ANF showed an additive effect with the inhibitory response of angiotensin II on adenylate cyclase from rat aorta. These studies for the first time demonstrate that ANF is an inhibitor of adenylate cyclase of several systems.

References

Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Jun 1, 1983·Archives of Biochemistry and Biophysics·M B Anand-Srivastava, M Cantin
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·N G SeidahT A Lyle
Sep 16, 1982·Biochemical and Biophysical Research Communications·M B Anand-SrivastavaJ Genest
Feb 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M J Muller, H P Baer
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·J GenestP Hamet
Dec 16, 1983·Biochemical and Biophysical Research Communications·M B Anand-Srivastava
Feb 27, 1984·FEBS Letters·G ThibaultM Chrétien
Oct 1, 1983·Biochemical Pharmacology·M B Anand-SrivastavaJ Genest

❮ Previous
Next ❯

Citations

Dec 1, 1988·Cellular and Molecular Neurobiology·G Skofitsch, D M Jacobowitz
Sep 15, 1986·Klinische Wochenschrift·A Kurtz
Apr 25, 1990·European Journal of Pharmacology·A P HoudijkH R De Jonge
May 13, 1985·Life Sciences·M B Anand-SrivastavaJ Genest
Feb 23, 1987·Life Sciences·T M StromF Bidlingmaier
Jan 1, 1991·Pharmacology & Therapeutics·D L Garbers
Oct 1, 1987·Regulatory Peptides·L T BudnikA K Mukhopadhyay
Apr 9, 1996·Regulatory Peptides·M JankowskiJ Gutkowska
May 30, 1985·Biochimica Et Biophysica Acta·S A WaldmanF Murad
Apr 1, 1989·Molecular and Cellular Endocrinology·W F OehlenschlagerM G Currie
Jul 2, 2003·Archives of Biochemistry and Biophysics·Malika BoumatiMadhu B Anand-Srivastava
Nov 28, 2007·Journal of Natural Products·Julia BensemhounEmile M Gaydou
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J HorvathA V Schally
Aug 1, 1997·Journal of Hypertension·M B Anand-Srivastava
Feb 1, 1986·Clinical and Experimental Pharmacology & Physiology·M HiwatariC I Johnston
Dec 1, 1985·The Journal of Clinical Investigation·B J Ballerman, B M Brenner
Jul 1, 1986·The Journal of Clinical Investigation·F Murad
May 25, 2005·Peptides·Kailash N Pandey
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·P J ChiuE J Sybertz
Jan 1, 1988·Fundamental & Clinical Pharmacology·P Lapalus, P P Elena

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.